Results 201 to 210 of about 14,157,417 (290)

[Clinical and obstetric characteristics in women with multiple sclerosis during pregnancy]. [PDF]

Rev Med Inst Mex Seguro Soc
Nava-Escobar ER, Mireles-Ramírez MA, Torres-Mendoza BM, Hernández-Preciado MR, Sánchez-Rosales NA, Márquez-Pedroza J.   +5 more
europepmc   +1 more source

Integration of highly focusing AlGaAs microlensed LED and double heterojunction bipolar transistors. [PDF]

, 1996
Kwon, Young Se
core  

Adaptive Pudendal Nerve Stimulation: A Pilot Study on Safety, Technical Feasibility, and Clinical Effect

Neurourology and Urodynamics, EarlyView.
ABSTRACT Purpose To evaluate the safety, procedural feasibility, and pilot clinical outcomes for a new implanted device delivering adaptive pudendal nerve stimulation. Materials and Methods Thirteen adult women with treatment‐refractory mixed (n = 8) or urge (n = 5) urinary incontinence were implanted with a Picostim‐DyNeuMo system incorporating an ...
Siemen Herroelen, Charles H. Knowles, Sean Doherty, Mo Benjaber, Jacob Kerr, Karen Wendt, Aidan Crawley, Tim Denison, Stefan De Wachter   +8 more
wiley   +1 more source

Professional identity and job performance among vocational education teachers-a chain mediation model of leader-member exchange and self-efficacy, with job crafting as a moderator. [PDF]

Front Psychol
Zhou Y, Zhong Z.
europepmc   +1 more source

A Novel Area-Variable Varactor Diode [PDF]

, 1994
Kwon, Young Se
core  

Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Intravesical oxybutynin (IVO) is a 2nd line treatment option for patients with neurogenic detrusor overactivity (NDO) who are not adequately managed by oral anticholinergics. The UPSIDE study aimed to identify urodynamic and anamnestic predictors for achieving a therapeutically satisfactory dose (TSD) of 1 mg/mL IVO and to ...
Arndt Van Ophoven, Severine Banek, Kristin Becker, Markus Heibel, Almut Hirsch, Margot Kieruj, Ines Kurze, Anja Lingnau, Barbara Ludwikowski, Tobias Luithle, Fabian Queissert, Wolfgang Rösch, Oliver Schindler, Regina Stredele, Thomas Michael Karl Völkl, Quentin Leidl, Michael Gedamke   +16 more
wiley   +1 more source

[Commercially available complementary foods in Argentina and Mexico: An analysis of their nutritional composition, labeling, and promotionAlimentos complementares comercializados na Argentina e no México: análise da composição nutricional, rotulagem e promoção]. [PDF]

Rev Panam Salud Publica
Zapata ME, Veliz P, Rovirosa A, Nessier MC, Risso Patrón V, De Bustos C, Gitz E, Crosbie E.   +7 more
europepmc   +1 more source

Dynamics of antiferromagnetic solitons [PDF]

, 2016
Kim, Se Kwon
core  

Oral GLP‐1RA TERN‐601 for Adults With Obesity/Overweight: Placebo‐Controlled, Multiple‐Ascending‐Dose, Phase 1 and 2 Studies

Obesity, EarlyView.
ABSTRACT Objective The safety, tolerability, pharmacokinetics, and efficacy of TERN‐601, a once‐daily, oral small‐molecule glucagon‐like peptide‐1 (GLP‐1) receptor agonist, were studied in Phase 1 and 2 clinical studies. Methods The Phase 1 (28‐day) and Phase 2 (12‐week), randomized, double‐blind, placebo‐controlled, multiple‐ascending‐dose studies ...
W. Timothy Garvey, Julio Rosenstock, Harold E. Bays, Douglas Denham, Anita Kohli, Melanie Haines, Christopher Jones, Ellen Kwan, Erin Castelloe, Tonya Marmon, Emil Kuriakose, Cara Nelson   +11 more
wiley   +1 more source